2010-11-01
Multi-component polymeric system for tumour cell-specific gene delivery using a universal bungarotoxin linker
Publication
Publication
Pharmaceutical Research , Volume 27 - Issue 11 p. 1- 9
Purpose: A new universal tool for specific, non-covalent and non-destructive attachment of a recombinant antibody fragment to a polymer-modified adenovirus has been utilised to regulate the tropism of adenoviral gene delivery vector. Methods: We have prepared a multivalent reactive N-(2-hydroxypropyl)methacrylamide-based copolymer (PHPMA) bearing an α-bungarotoxin-binding peptide (BTXbp). The copolymer was used for covalent surface modification of adenoviral vectors (Ad). The α-bungarotoxin protein (BTX) has a nanomolar binding affinity for BTXbp, allowing non-covalent linkage of BTX fusion proteins. A single chain variable fragment of anti-PSMA antibody bearing BTX (scFv-BTX) binding to the prostate-specific membrane antigen (PSMA) was conjugated with the copolymer-coated adenovirus to enable specific infection of prostate cancer cells via PSMA receptors. Results: As shown by ELISA, the copolymer-coated virus exhibited much reduced binding to anti-Ad antibodies. Infection of PC-3 and LNCaP prostate cancer cells was ∼100-fold less efficient with copolymer-coated Ad than with un-modified Ad. Conjugation of scFv-BTX with Ad-PHPMA-BTXbp led to 5-10-fold restoration of infection in PSMA-positive LNCaP cells. In PSMA-negative PC-3 cells, the conjugation of scFv-BTX with Ad-PHPMA-BTXbp gave no enhancement of infection. Conclusions: We have shown that the presented Ad-PHPMA-BTXbp/scFv-BTX system can be used as a universal tool for a receptor-specific virotherapy.
Additional Metadata | |
---|---|
, , , , | |
doi.org/10.1007/s11095-010-0088-8, hdl.handle.net/1765/21835 | |
Pharmaceutical Research | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Willemsen, R., Pechar, M., Carlisle, R., van Schooten, E., Pola, R., Thompson, A., … Ulbrich, K. (2010). Multi-component polymeric system for tumour cell-specific gene delivery using a universal bungarotoxin linker. Pharmaceutical Research, 27(11), 1–9. doi:10.1007/s11095-010-0088-8 |